Compare ELVN & FBRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELVN | FBRT |
|---|---|---|
| Founded | 2016 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 882.8M |
| IPO Year | 2020 | 1985 |
| Metric | ELVN | FBRT |
|---|---|---|
| Price | $17.23 | $10.75 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | ★ $41.20 | $14.75 |
| AVG Volume (30 Days) | ★ 661.3K | 644.3K |
| Earning Date | 11-12-2025 | 10-29-2025 |
| Dividend Yield | N/A | ★ 13.27% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.80 |
| Revenue | N/A | ★ $241,051,000.00 |
| Revenue This Year | N/A | $28.41 |
| Revenue Next Year | N/A | $50.77 |
| P/E Ratio | ★ N/A | $13.39 |
| Revenue Growth | N/A | ★ 32.77 |
| 52 Week Low | $13.30 | $9.71 |
| 52 Week High | $25.37 | $13.58 |
| Indicator | ELVN | FBRT |
|---|---|---|
| Relative Strength Index (RSI) | 34.79 | 63.80 |
| Support Level | $16.62 | $10.48 |
| Resistance Level | $20.47 | $10.68 |
| Average True Range (ATR) | 1.35 | 0.16 |
| MACD | -0.48 | 0.06 |
| Stochastic Oscillator | 8.40 | 90.29 |
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
Franklin BSP Realty Trust Inc is a private real estate investment trust that originates, acquires, and manages a diversified portfolio of commercial real estate debt, and first mortgage loans. secured by properties located in the United States. Its segments include the real estate debt business; the real estate securities business; the real estate owned business; and the commercial real estate conduit business.